Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Stroke. 2010 Apr 15;41(6):1213–1221. doi: 10.1161/STROKEAHA.109.570077

Figure 2.

Figure 2

Flowchart of patients excluded from the study and included patients randomized to active treatment with 5 mg/d donepezil or placebo. TIA indicates transient ischemic attack. *Patients might have >1 reason for screen failure, and some patients were screened more than once. †Twenty-five patients were excluded from the ITT population because they did not have a baseline assessment in addition to at least 1 postbaseline assessment for at least 1 of the primary efficacy variables. ‡Eleven patients died during the study (all in the donepezil group).